Evidence map›Paper›PMID 25132068›Full record

ArticleRejuvenation research2014

The scientific quest for lasting youth: prospects for curing aging.

João Pedro de Magalhães

Abstract read
In one paragraph

Article in Rejuvenation research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Coenzyme Q10: A Life Extension Nutrient & The Crystallization Problem.Integrative medicine (Encinitas, Calif.) · 2026
    Article
  3. Article
  4. Article
  5. Pharmacology of Aging:Aging biology · 2024
    Article
  6. Review
  7. Review
  8. Article
  9. Evolutionary Approaches in Aging Research.Cold Spring Harbor perspectives in medicine · 2022
    Review
  10. Article
  11. Article
  12. Insights from evolutionarily relevant models for human ageing.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2020
    Article
  13. Article
  14. Sarcopenia: Aging-Related Loss of Muscle Mass and Function.Physiological reviews · 2019 · on this map
    Review
  15. Biogerontology: research status, challenges and opportunities.Acta bio-medica : Atenei Parmensis · 2018
    Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

João Pedro de MagalhãesIntegrative Genomics of Ageing Group, Institute of Integrative Biology, University of Liverpool , Liverpool, United Kingdom .

Funding

Biotechnology and Biological Sciences Research Council BB/G024774/1Biotechnology and Biological Sciences Research Council BB/H008497/1Biotechnology and Biological Sciences Research Council BB/K016741/1Wellcome Trust WT094386MA
6 · The paper itself

Abstract

People have always sought eternal life and everlasting youth. Recent technological breakthroughs and our growing understanding of aging have given strength to the idea that a cure for human aging can eventually be developed. As such, it is crucial to debate the long-term goals and potential impact of the field. Here, I discuss the scientific prospect of eradicating human aging. I argue that curing aging is scientifically possible and not even the most challenging enterprise in the biosciences. Developing the means to abolish aging is also an ethical endeavor because the goal of biomedical research is to allow people to be as healthy as possible for as long as possible. There is no evidence, however, that we are near to developing the technologies permitting radical life extension. One major difficulty in aging research is the time and costs it takes to do experiments and test interventions. I argue that unraveling the functioning of the genome and developing predictive computer models of human biology and disease are essential to increase the accuracy of medical interventions, including in the context of life extension, and exponential growth in informatics and genomics capacity might lead to rapid progress. Nonetheless, developing the tools for significantly modifying human biology is crucial to intervening in a complex process like aging. Yet in spite of advances in areas like regenerative medicine and gene therapy, the development of clinical applications has been slow and this remains a key hurdle for achieving radical life extension in the foreseeable future.

Indexed as

AgingErgonomicsHumansLongevityRegenerative MedicineRejuvenation

Identifiers

PMID25132068
PMCPMC4203147

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.